Episode 40: Theranostics: The Leading Edge of Precision Care in Cancer Treatment

Episode 40: Theranostics: The Leading Edge of Precision Care in Cancer Treatment

May 26, 2025 · 32 min · Episode 40

About this episode

This episode explores theranostics, a patient-centric approach in cancer treatment, featuring insights from industry leaders.

This podcast was created with support from GE HealthCare Canada. Theranostics is a patient-centric approach in medicine that combines diagnostic and therapeutic technologies to precisely visualize and treat cancer without harming healthy tissue. This innovative treatment method is an incredible showcase of technology in the health care system. Featuring Mike Hamilton, CEO of GE HealthCare Canada, and Dr. Narinder Paul, Chief of Medical Imaging at St. Joseph’s Health Care London, this podcast explores the key aspects of theranostics, how it functions, the challenges of implementation in Canada, current applications, and a successful example of theranostics adoption in Ontario. In this episode, we will learn about the real-world impact of theranostics and its potential to revolutionize patient care across Canada. -- Mike Hamilton, Chief Executive Officer, GE HealthCare Canada Mike Hamilton is a senior executive and board member with over 30 years’ experience in health care and medical technology, gained through progressively senior commercial and executive roles in Canada and internationally. Since September 2022, he has served as the President and CEO of GE HealthCare Canada…

People in this episode

Guests: Mike Hamilton, Dr. Narinder Paul

Sponsors

GE HealthCare Canada

Mentioned in this episode

Organizations: St. Joseph’s Health Care London, C.D. Howe Institute

More episodes of From the Burgundy Chairs

Explore listener stats, chart rankings, contacts and more on the From the Burgundy Chairs podcast page.